DJIA 17,810.06 91.06 0.51%
NASDAQ 4,712.97 11.10 0.24%
S&P 500 2,063.50 10.75 0.52%
market minute promo

Seattle Genetics (NASDAQ: SGEN)

36.85 0.25 (0.68%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

SGEN $36.85 0.68%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $37.13
Previous Close $36.60
Daily Range $36.42 - $37.80
52-Week Range $30.80 - $55.99
Market Cap $4.6B
P/E Ratio -70.38
Dividend (Yield) $0.00 (0.0%)
Volume 1,037,451
Average Daily Volume 1,302,334
Current FY EPS -$0.68

Sector

Healthcare

Industry

Drugs

Seattle Genetics (SGEN) Description

A biotechnology company, which develops monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases. Website: http://www.seattlegenetics.com/

News & Commentary

3 Biotech Stocks to Watch in November

Biotech can be a tough sector for many investors. Here, our analysts share their three favorite picks as we go into November.

Seattle Genetics Inc. (SGEN): New Analyst Report from Zacks Equity Research - Zacks Equity Research

Seattle Genetics Inc. (SGEN): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report

Why the Earnings Streak Will Continue for Seattle Genetics (SGEN) - Tale of the Tape

Friday's ETF Movers: GDXJ, BBH

5 Stocks With Big Insider Buying

Seattle Genetics (SGEN) Shows Signs Of Being Water-Logged And Getting Wetter

5 Health Care Stocks Hurting From The Affordable Care Act

Seattle Genetics Gains on Narrower-than-Expected Q3 Loss - Analyst Blog

Seattle Genetics' (SGEN) CEO Clay Siegall on Q3 2014 Results - Earnings Call Transcript

Analysts' Actions: Aegerion, Atmel, Avon, Seattle Genetics, More

See More SGEN News...

SGEN's Top Competitors

SGEN $36.85 (0.68%)
Current stock: SGEN
GILD $100.58 (-0.01%)
Current stock: GILD
AMGN $162.81 (0.08%)
Current stock: AMGN
BIIB $303.55 (1.49%)
Current stock: BIIB